{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "2572964", "DateCompleted": {"Year": "1989", "Month": "11", "Day": "30"}, "DateRevised": {"Year": "2016", "Month": "11", "Day": "23"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0885-3185", "JournalIssue": {"Volume": "4", "Issue": "4", "PubDate": {"Year": "1989"}}, "Title": "Movement disorders : official journal of the Movement Disorder Society", "ISOAbbreviation": "Mov Disord"}, "ArticleTitle": "Betel nut-induced extrapyramidal syndrome: an unusual drug interaction.", "Pagination": {"StartPage": "330", "EndPage": "332", "MedlinePgn": "330-2"}, "Abstract": {"AbstractText": ["Two cases are described of chronic schizophrenic patients maintained on depot neuroleptics, who developed severe extrapyramidal symptoms following a period of heavy betel nut consumption. A mechanism for this effect is proposed based on the pharmacological antagonism of the anticholinergic agent, procyclidine, by the active alkaloid ingredient of the betel, arecoline."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Maudsley Hospital, Denmark Hill, London, England."}], "LastName": "Deahl", "ForeName": "M", "Initials": "M"}], "PublicationTypeList": ["Case Reports", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Mov Disord", "NlmUniqueID": "8610688", "ISSNLinking": "0885-3185"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antipsychotic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrrolidines"}, {"RegistryNumber": "4ALN5933BH", "NameOfSubstance": "Arecoline"}, {"RegistryNumber": "C6QE1Q1TKR", "NameOfSubstance": "Procyclidine"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Antipsychotic Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Areca"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Arecoline"}, {"QualifierName": ["etiology", "prevention & control"], "DescriptorName": "Basal Ganglia Diseases"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "India"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["adverse effects", "metabolism", "therapeutic use"], "DescriptorName": "Procyclidine"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Pyrrolidines"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Schizophrenia"}, {"QualifierName": [], "DescriptorName": "Travel"}, {"QualifierName": [], "DescriptorName": "United Kingdom"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1989", "Month": "1", "Day": "1"}, {"Year": "1989", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1989", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["2572964", "10.1002/mds.870040406"]}}]}